(To see other currencies, click on price)
MORE ABOUT THIS BOOK
Main description:
This volume provides a comprehensive overview of the development, pharmacology, efficacy, and safety of the currently available TNF-alpha inhibitors. It is the first volume that summarizes this material for all available TNF-alpha inhibitors. Elevated levels of TNF-alpha have been demonstrated in Crohn's disease, psoriasis, psoriatic arthritis, and rheumatoid arthritis, suggesting a role for TNF-alpha in their pathogenesis. The most recent preclinical and clinical data is presented in this book.
Contents:
Preface.- Introduction to TNF/Pathophysiology of TNF.- History of development of TNF inhibitors.- Pharmacology of TNF inhibitors.- Etanercept in rheumatology.- Etanercept in dermatology and off-label use.- Infliximab in rheumatology.- Infliximab in dermatology, gastroenterology and off-label use.- Adalimumab in rheumatology.- Adalimumab in dermatology.- A review of the safety of the tumor necrosis inhibitors infliximab, etanercept, and adalimumab.
PRODUCT DETAILS
Publisher: Springer (Birkhauser Verlag AG)
Publication date: May, 2006
Pages: 143
Weight: 840g
Availability: Available
Subcategories: Dermatology, Gastroenterology, Immunology, Orthopaedics and Fractures, Pharmacology, Rheumatology
From the same series
